iopamidol has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruschetta, G; Cordaro, M; Crupi, R; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Siracusa, R | 1 |
| Narasaki, K | 1 |
| Armini, L; Artero, M; Calci, M; Candido, R; Carraro, M; Carretta, R; Fabris, B; Faccini, L; Mancini, W; Zennaro, C | 1 |
3 other study(ies) available for iopamidol and Alloxan Diabetes
| Article | Year |
|---|---|
A novel protective formulation of Palmitoylethanolamide in experimental model of contrast agent induced nephropathy.
Topics: Acute-Phase Proteins; Amides; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Urea Nitrogen; Contrast Media; Creatinine; Diabetes Mellitus, Experimental; Disease Models, Animal; Ethanolamines; Glutathione Transferase; In Situ Nick-End Labeling; Iohexol; Iopamidol; Kidney; Lipocalin-2; Lipocalins; Male; Palmitic Acids; Particle Size; Potassium; Proto-Oncogene Proteins; Rats; Rats, Wistar; Renal Insufficiency; Sodium; Streptozocin | 2016 |
[Contrast-associated nephrotoxicity: ultrastructural and biochemical study in diabetic rats].
Topics: Animals; Contrast Media; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diatrizoate; Iopamidol; Ioxaglic Acid; Kidney; Male; Rats; Rats, Wistar; Streptozocin; Triiodobenzoic Acids | 1997 |
Albumin permeability in isolated glomeruli in incipient experimental diabetes mellitus.
Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Glomerular Filtration Rate; Hyperglycemia; In Vitro Techniques; Insulin; Iopamidol; Kidney Glomerulus; Male; Permeability; Proteinuria; Rats; Rats, Inbred WKY; Rats, Wistar; Reference Values; Serum Albumin, Bovine | 2000 |